Europe Set to Approve the West's First Gene Therapy Treatment

The governmental body that overseas European health regulations is set to be the first in the Western world to approve a specific gene therapy to treat a genetic disease. 

What's the Latest Development?

The governmental body that oversees European health regulations is set to approve a specific gene therapy to treat a rare genetic disease, perhaps lending the beleaguered medical field some long-awaited support. The therapy, called Glybera, will treat lipoprotein lipase deficiency, a genetic mutation that prevents those affected from "producing an enzyme needed to break down certain fat-carrying particles that circulate in the bloodstream after meals." The therapy is administered through several shots into the leg muscle and is expected to allow patients to produce the important enzyme for at least a few years. 

What's the Big Idea?

Gene therapy has long been promised as a novel and effective way to treat genetic diseases but setbacks during the 1990s, including the death of a teenager during a clinical trial in Pennsylvania, have delayed its approval. "But researchers have been slowly overcoming the obstacles and in the last few years there have been reports of successes in attempts to treat cancerhemophilia B, certain immune diseases and a condition that causes blindness." Dr. Mark A. Kay, a professor of pediatrics and genetics at Stanford, says: "It didn’t occur as rapidly, I think, as people had kind of promised or suggested 15 or 20 years ago, but we are starting to see success."

Photo credit:

Biohacking: Why I'll live to be 180 years old

From computer hacking to biohacking, Dave Asprey has embarked on a quest to reverse the aging process.

  • As a teenager, founder of Bulletproof, Dave Asprey, began experiencing health issues that typically plague older adults.
  • After surrounding himself with anti-aging researchers and scientists, he discovered the tools of biohacking could dramatically change his life and improve his health.
  • He's now confident he'll live to at least 180 years old. "It turns out that those tools that make older people young make younger people kick ass," he says.
Keep reading Show less

First solar roadway in France turned out to be a 'total disaster'

French newspapers report that the trial hasn't lived up to expectations.

Image source: Charly Triballeau / AFP / Getty Images
Technology & Innovation
  • The French government initially invested in a rural solar roadway in 2016.
  • French newspapers report that the trial hasn't lived up to expectations.
  • Solar panel "paved" roadways are proving to be inefficient and too expensive.
Keep reading Show less

European wind farms could meet global energy demand, researchers now say

A new study estimated the untapped potential of wind energy across Europe.

Surprising Science
  • A new report calculated how much electricity Europe could generate if it built onshore wind farms on all of its exploitable land.
  • The results indicated that European onshore wind farms could supply the whole world with electricity from now until 2050.
  • Wind farms come with a few complications, but the researchers noted that their study was meant to highlight the untapped potential of the renewable energy source in Europe.
Keep reading Show less